This statistic shows the total cost of research and development (R&D) including a 7 percent per annum cost of capital for select cancer drugs that were on the market as of 2017. Alexion Pharmaceuticals' drug Eculizumab had a total R&D cost, including capital, of around 1.09 billion U.S. dollars as of 2017. Total R&D costs without the 7 percent of annual cost of capital stood at some 818 million dollars.
Total R&D costs including 7 percent annual cost of capital for select cancer drugs on the market as of 2017
(in million U.S. dollars)
This statistic includes only pharmaceutical companies with a single oncologic drug approved by the Food and Drug Administration (FDA). Values are inflation adjusted for 2017 U.S. dollars.
* Alexion later had two drug approvals in the last quarter of 2015; these drugs are not included in this statistic.
** Compound acquired by the company on this date.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Statista Accounts:
Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.
JAMA. (November 1, 2017). Total R&D costs including 7 percent annual cost of capital for select cancer drugs on the market as of 2017 (in million U.S. dollars) [Graph]. In Statista. Retrieved May 26, 2022, from https://www.statista.com/statistics/788904/randd-costs-for-select-cancer-drugs-including-capital/
JAMA. "Total R&D costs including 7 percent annual cost of capital for select cancer drugs on the market as of 2017 (in million U.S. dollars)." Chart. November 1, 2017. Statista. Accessed May 26, 2022. https://www.statista.com/statistics/788904/randd-costs-for-select-cancer-drugs-including-capital/
JAMA. (2017). Total R&D costs including 7 percent annual cost of capital for select cancer drugs on the market as of 2017 (in million U.S. dollars). Statista. Statista Inc.. Accessed: May 26, 2022. https://www.statista.com/statistics/788904/randd-costs-for-select-cancer-drugs-including-capital/
JAMA. "Total R&d Costs including 7 Percent Annual Cost of Capital for Select Cancer Drugs on The Market as of 2017 (in Million U.S. Dollars)." Statista, Statista Inc., 1 Nov 2017, https://www.statista.com/statistics/788904/randd-costs-for-select-cancer-drugs-including-capital/
JAMA, Total R&D costs including 7 percent annual cost of capital for select cancer drugs on the market as of 2017 (in million U.S. dollars) Statista, https://www.statista.com/statistics/788904/randd-costs-for-select-cancer-drugs-including-capital/ (last visited May 26, 2022)
